Organometallics
Article
(m, 7 H, Ar−H), 5.92 (s, 2 H, NCH2Ph), 5.85 (s, 2 H, NCH2Ph), 4.18
(s, 2 H, CH2S), 2.13 (s, 3 H, CH3). 13C{1H} NMR (75.47 MHz,
CDCl3): δ 195.1 (CO), 143.6 (NCHN), 136.3, 133.2, 132.0, 131.81,
131.79, 131.0, 130.1, 129.7, 129.6, 129.4, 129.1, 129.0, 127.8, 127.7,
114.5, 114.3 (Ar−C), 52.1, 49.5 (NCH2Ph), 31.2 (CH2S), 30.8
(CH3). One signal for an aromatic carbon atom is not observed due to
accidental overlap. MS (ESI): m/z 387 [M − Br]+.
Ar−H), 6.86 (d, 1 H, Ar−H), 6.41 (s, 2 H, NCH2Ph), 6.13 (s, 2 H,
NCH2Ph), 4.17 (s, 2 H,CH2SO3), 3.06 (s, 12 H, NMe4), 1.96 (s,
CH3CN, correct integration is not possible due to ligand exchange
with the solvent). 13C{1H} NMR (125.77 MHz, CD3CN): δ 162.6
(NCN), 136.1, 135.4, 135.2, 134.9, 133.5, 133.2, 129.6, 129.03, 128.96,
128.2, 128.0, 127.8, 124.5, 124.4 (Ar−C), 118.1 (CN), 113.1, 112.4
1
(Ar−C), 56.1 (t, J(C,N) = 3.7 Hz, NMe4), 55.5, 53.8 (NCH2Ph),
51.0 (CH2SO3), 1.32 (m, CH3CN, assignment is tentative due to
overlap with solvent signals). Two signals accidently overlap at 128.8
ppm. Anal. Calcd for C28H34Br2N4O3PdS: C, 43.51; H, 4.43; N, 7.25.
Found: C, 43.23; H, 4.49; N, 7.24. MS (ESI): m/z 74 [NMe4]+, −659
[M − NMe4 − CH3CN]−.
Aqueous Mizoroki−Heck Catalysis. In a typical run, a reaction
tube was charged with a mixture of aryl halide (0.3 mmol), base (0.45
mmol), tert-butyl acrylate (0.42 mmol), catalyst (0.003 mmol), TBAB
(0.45 mmol when necessary), and solvent. The reaction was stirred at
110 °C for the desired time. After the mixture was cooled to ambient
temperature, dichloromethane (2 mL) was added. The organic layer
was then washed with water (6 × 8 mL) and dried over Na2SO4. The
solvent was allowed to evaporate, and the residue was analyzed by 1H
NMR spectroscopy.
X-ray Diffraction Studies. X-ray data for 3, 4, and 6 were
collected with a Bruker AXS SMART APEX diffractometer, using Mo
Kα radiation with the SMART suite of programs.16 Data were
processed and corrected for Lorentz and polarization effects with
SAINT17 and for absorption effect with SADABS.18 Structural solution
and refinement were carried out with the SHELXTL suite of
programs.19 The structure was solved by direct methods to locate
the heavy atoms, followed by difference maps for the light, non-
hydrogen atoms. All non-hydrogen atoms were generally given
anisotropic displacement parameters in the final model. All H atoms
were put at calculated positions. A summary of the most important
crystallographic data is given in Table S1 in the Supporting
Information.
Dinuclear Complexes 2 and 3. A mixture of salt D/E (405/467
mg, 1.0 mmol) and Pd(OAc)2 (224 mg, 1.0 mmol) in DMSO (5 mL)
was stirred at 80 °C overnight. The resulting suspension was filtered,
and the yellow solid was washed with H2O (3 × 20 mL) and dried to
give the products. Complex 2: 277 mg, 0.3 mmol, 60%. 1H NMR (300
MHz, CDCl3): δ 7.50−7.19 (m, 18 H, Ar−H), 6.44 (d, 2J(H,H) = 15.6
2
Hz, 2 H, NCHHPh), 5.37 (d, J(H,H) = 15.6 Hz, 2 H, NCHHPh),
4.83−4.77 (m, 2 H, NCHH), 3.10−2.91 (m, 4 H, CH2), 2.26 (br s, 2
H, CH2). Signals for another two CH2 groups were not resolved. Anal.
Calcd for C34H34Br2N4Pd2S2: C, 43.66; H, 3.66; N, 5.99. Found: C,
43.61; H, 4.07; N, 5.52. MS (ESI): m/z 856 [M − Br]+. Complex 3:
1
403 mg, 0.38 mmol, 76%. H NMR (500 MHz, CDCl3): δ 7.59 (d, 2
H, Ar−H), 7.43−7.39 (m, 4 H, Ar−H), 7.35−7.32 (m, 8 H, Ar−H),
7.22−7.09 (m, 12 H, Ar−H and NCHHPh), 7.07−7.06 (m, 2 H, Ar−
H), 6.96−6.88 (m, 2 H, NCHH), 5.32 (d, 2 H, NCHHPh), 4.91−4.81
2
(m, 2 H, NCHH), 4.39 (d, J(H,H) = 15.1 Hz, 1 H, NCHHS), 4.22
(d, 2J(H,H) = 15.1 Hz, 1 H, NCHHS), 2.63 (d, 2J(H,H) = 15.1 Hz, 2
H, NCHHS). Anal. Calcd for C44H38Br2N4Pd2S2·H2O: C, 49.04; H,
3.74; N, 5.20. Found: C, 48.72; H, 3.48; N, 5.05%. MS (ESI): m/z 979
[M − Br]+. The 13C NMR spectra of complexes 2 and 3 could not be
obtained due to poor solubility.
Sulfonate Complex 4. Complex 1 (45 mg, 0.05 mmol), Oxone
(92 mg, 0.15 mmol), and NMe4Br (39 mg, 0.25 mmol) in DMF (5
mL) and H2O (2 mL) were stirred at ambient temperature overnight.
After the solvent was removed, the resulting solid was triturated with
CH3CN (3 × 5 mL) and the suspension filtered. The solvent of the
filtrate was removed, and the residue was washed with H2O (3 × 3
mL) and redissolved in CH3CN (5 mL). Removal of the solvent gave
the product as a yellow powder. A second batch was obtained by
removing the solvent of the aqueous solution, washing the residue with
a little H2O (3 × 1 mL), and recrystallization in CH3CN (5 mL) (60
mg, 0.086 mmol, 86%). 1H NMR (500 MHz, CD3CN): δ 7.62 (d, 1 H,
Ar−H), 7.54 (d, 2 H, Ar−H), 7.53−7.30 (m, 4 H, Ar−H), 7.17−7.14
(m, 2 H, Ar−H), 6.04 (s, 2 H, NCH2Ph), 5.12−5.09 (m, 2 H, NCH2),
3.34−3.31 (m, 2 H, CH2SO3), 3.10 (s, 12 H, NMe4), 1.96 (s, CH3CN,
correct integration is not possible due to ligand exchange with the
solvent). 13C{1H} NMR (125.77 MHz, CD3CN): δ 161.4 (NCN),
135.9, 135.1, 134.6, 129.4, 128.89, 128.87, 124.5, 124.2 (Ar−C), 118.3
ASSOCIATED CONTENT
* Supporting Information
Crystallographic data for 3, 4, and 6 (CCDC 977882−977884)
as CIF files. This material is available free of charge via the
■
S
AUTHOR INFORMATION
Corresponding Author
■
1
(CN), 112.2, 111.9 (Ar−C), 56.0 (t, J(C,N) = 4.1 Hz, NMe4), 53.6
Notes
(NCH2Ph), 50.8 (NCH2), 46.4 (CH2SO3), 1.32 (m, CH3CN,
assignment is tentative due to overlap with solvent signals). Anal.
Calcd for C22H30Br2N4O3PdS: C, 37.92; H, 4.34; N, 8.04. Found: C,
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
+
37.52; H, 4.38; N, 8.12. MS (ESI): m/z 74 NMe4 , −581 [M − NMe4
■
− CH3CN]−.
The authors thank the National University of Singapore and
the Singapore Ministry of Education (MOE) for financial
support (WBS R-143-000-483-112). Technical support from
staff at the CMMAC of our department is appreciated. In
particular, we thank Ms. Geok Kheng Tan and Prof. Lip Lin
Koh for determining the X-ray molecular structures.
Sulfonate Complexes 5 and 6. Complexes 5 and 6 were
synthesized in analogy to 4 from 2/3 (187/212 mg, 0.2 mmol), Oxone
(369 mg, 0.6 mmol), and NMe4Br (154 mg, 1.0 mmol). Complex 5:
1
214 mg, 0.3 mmol, 75%. H NMR (300 MHz, CD3CN): δ 7.80 (d, 1
H, Ar−H), 7.53−7.52 (m, 2 H, Ar−H), 7.33−7.29 (m, 4 H, Ar−H),
7.15−7.13 (m, 2 H, Ar−H), 6.05 (s, 2 H, CH2Ph), 4.99 (ps t, 2 H,
NCH2), 3.10 (s, 12 H, NMe4), 2.78 (ps t, 2 H,CH2SO3), 2.54−2.47
(m, 2 H, CH2), 1.96 (s, CH3CN, correct integration is not possible
due to ligand exchange with the solvent). 13C{1H} NMR (75.47 MHz,
CD3CN): δ 160.8 (NCN), 136.0, 135.4, 134.5, 129.3, 128.8, 124.4,
REFERENCES
■
(1) (a) Bierenstiel, M.; Cross, E. D. Coord. Chem. Rev. 2011, 255,
574. (b) Yuan, D.; Huynh, H. V. Molecules 2012, 17, 2491.
1
(2) (a) Moore, L. R.; Cooks, S. M.; Anderson, M. S.; Schanz, H.-J.;
Griffin, S. T.; Rogers, R. D.; Kirk, M. C.; Shaughnessy, K. H.
Organometallics 2006, 25, 5151. (b) Papini, G.; Pellei, M.; Lobbia, G.
G.; Burini, A.; Santini, C. Dalton Trans. 2009, 6985. (c) Azua, A.; Sanz,
S.; Peris, E. Organometallics 2010, 29, 3661. (d) Virboul, M. A. N.;
Lutz, M.; Siegler, M. A.; Spek, A. L.; van Koten, G.; Gebbink, R. J. M.
K. Chem.Eur. J. 2009, 15, 9981. (e) Godoy, F.; Segarra, C.; Poyatos,
M.; Peris, E. Organometallics 2011, 30, 684. (f) Azua, A.; Sanz, S.;
Peris, E. Chem.Eur. J. 2011, 17, 3963. (g) Silbestri, G. F.; Flores, J.
124.1(Ar−C), 118.1 (CN), 112.2, 112.1 (Ar−C), 55.9 (t, J(C,N) =
4.1 Hz, NMe4), 53.5 (NCH2Ph), 49.1 (NCH2), 48.5 (CH2SO3), 26.1
(CH2), 1.32 (m, CH3CN, assignment is tentative due to overlap with
solvent signals). Two signals accidently overlap at 128.8 ppm. Anal.
Calcd for C23H32Br2N4O3PdS: C, 38.86; H, 4.54; N, 7.88. Found: C,
38.56; H, 4.60; N, 7.90. MS (ESI): m/z 74 [NMe4]+, −595 [M −
1
NMe4 − CH3CN]−. Complex 6: 231 mg, 0.3 mmol, 74%. H NMR
(500 MHz, CD3CN): δ 7.59 (d, 2 H, Ar−H), 7.41−7.33 (m, 4 H, Ar−
H), 7.22 (t, 1 H, Ar−H), 7.17−7.11 (m, 4 H, Ar−H), 7.04 (t, 1 H,
1799
dx.doi.org/10.1021/om500140g | Organometallics 2014, 33, 1794−1800